top of page
Rapid Start-up Network
for Clinical Trials
Capabilities of the Rapid Start-up Network
The Central & Eastern Europe Research Institute has developed a Rapid Start-up Network of hospitals and clinics to accelerate clinical research timelines while ensuring the selection of high-quality sites. CEERI aims to assist Sponsors and CROs in streamlining the study start-up process and providing resources to sites, ensuring successful patient recruitment and project delivery
Extensive Network
of Sites
CEERI’s extensive network of sites provides access to highly qualified investigators and state-of-the art medical infrastructure throughout Central & Eastern Europe
Strong Site Relationships
Established relationships with research sites ensure smooth communication and collaboration, leading to more efficient trial management
Infrastructure and Technological Advancements
The necessary infrastructure and technological capabilities for health research. Modern hospitals, research centers, and laboratories support the execution of clinical trials
Accelerated Timelines
The network speeds up the initiation of clinical trials by quickly identifying and activating high-quality research sites that best suit the trial's objectives
Cost-Effectiveness
Lower regulatory, operational, and labor costs compared to Western Europe and the US, making the region cost-effective for conducting trials
Legal Framework and Good Regulations
Clinical trials in CEE adhere to
a robust legal framework and regulations. This ensures that research is conducted in compliance with ethical and legal standards
Access to Large Patient Populations
Secure enrollment due to access to large and diverse patient populations served by well-equipped sites and experienced investigators across CEE region
Qualified Healthcare Professionals
Highly trained and experienced healthcare professionals with strong academic backgrounds, with most investigators holding teaching positions at major medical universities
Enhanced Data Quality
Standardized procedures and protocols across sites ensure high-quality and reliable data collection
We operate in over 500 hospitals and clinics
across 20 Central & Eastern European Countries
Armenia
Azerbaijan
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Georgia
Hungary
Latvia
Lithuania
Moldova
Montenegro
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Turkiye
Therapeutic Areas Covered
Respiratory
Metabolic
Cardiovascular
Infectious Diseases
Bioequivalence
Ear, Nose & Throat
Oncology
Cell & Gene Therapy
Pharmacology
Gastrointestinal
Psychiatry
Central Nervous System
Pediatric
Hematology
Nephrology
Rheumatology
Immunology
bottom of page